Clinical Trials
4 trialsNCT02603328 2025-08-22
AT CASH EPOC
University of Chicago
Phase 1/2 Completed
NCT05085561 2025-08-06
SYCAMORE
Recursion Pharmaceuticals Inc.
Phase 2 Completed
NCT03652181 2024-06-27
CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness
University of Chicago
Completed
NCT03589014 2022-02-25
Treat_CCM
Mario Negri Institute for Pharmacological Research
Phase 2 Completed